ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently operates from 77 locations in 38 countries and has approximately 11,700 employees.
Further information is available at www.iconplc.com and http://careers.iconplc.com/.
ICON plc has a strong reputation in our approaches to clinical development. We apply scientific and operational excellence across all phases of clinical trial outsourcing services for our clients. We work with top pharmaceutical organisations on emerging therapeutic areas which include, but are not limited, to Oncology, Vaccines, CNS, Cardiovascular and CNS.
We support our CRAs with manageable sites and protocols, offer a strong benefits package that includes a comprehensive health plan, retirement plan, competitive pay, four weeks’ paid time off, compressed work weeks and eligibility for the annual performance bonus. Additionally, we have cutting-edge technology to ensure the future state of monitoring and a dedicated management team to support our CRAs in the field, including our first-class Training Management system: iLearn.
We pride ourselves in focusing on training, innovation and technology, work-life balance, career progression and culture and values.
To learn more about life as a CRA please visit http://careers.iconplc.com/clinical-research-associate-jobs
ICON is committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times.
We offer a full range of consulting, development and commercialisation services from a global network of offices in 37 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality – and our global team of experts has unparalleled experience in a broad range of therapeutic areas. – less